Accord Pharmaceuticals launches IPO, Global Sales Manager Global IME Capital

Accord Pharmaceuticals Limited is going to issue 480,000 IPO alots to the public. The company has appointed Global IME Capital as the issue and sale manager for the public issue of 480,000 ordinary shares at a face value of Rs 100 per share.In this regard, an agreement has been reached between the company and Capital regarding the issue of shares. The agreement was signed by Chairman Vishal Pandit on behalf of Accord Pharmaceuticals and Chief Executive Officer Paras Mani Dhakal on behalf of Global IME Capital at a function held at Global IME Capital’s central office Naxal on December 7.

With an authorized capital of Rs. 650 million and an issued capital .